Navigation Links
Monterey Bay Nutraceuticals Announces Launch of Website
Date:4/28/2013

Newport Beach, California (PRWEB) April 28, 2013

Vestiage, Inc., a publicly traded anti-aging lifestyle company focused on science-based research and development, sales and marketing of premium-branded, highly effective anti-aging cosmeceuticals and nutraceuticals, announced today that it has launched a website for its over-40, female-focused nutraceutical brand, Monterey Bay Nutraceuticals. Pre-orders for the product are being accepted on the site.

Scott Kimball, CEO of Vestiage stated, "This is a revolutionary line of nutraceuticals that are focused on the most important "in demand" issues of our specific consumer and clientele, the premium and prestige woman over 40. These concerns are skin elasticity, skin moisturization, antioxidant protection, UV ray protection, weight management, enhanced and sustained energy levels, providing a calm mood and sense of wellbeing during menopause, supporting more restful sleep, reducing the production of cortisol, reducing body fat. We named them precisely to tell peole what they do: Calm and Collected, Trim and Energized, and SuperSoftSkin! The elegant and potent formulations, the delivery mechanism, the patented ingredients and sourcing, the packaging, the messaging have all been very carefully tested and accomplished in conjunction with "blue-chip" partners like Robinson Pharma and Nutragenesis. We could not be more pleased with the results."

The Monterey Bay Nutraceuticals brand was conceived by Vestiage Founder Kimball while walking the beach in Monterey Bay. This led to meetings with Moss Landing Marine Laboratories, Robinson Pharma, Nutragenesis and research sponsored by Vestiage, Inc. (the owner of Monterey Bay Nutraceuticals) into the latest marine and botanical science and advances. The research discovered patented ingredients and Vestiage created a formulation philosophy for Monterey Bay Nutraceuticals, driven by the consumers' demand for multifunctional pills (fewer pills in the regimen), stronger and more effective ingredient profiles, and fast acting and enhanced bioavailable ingredient delivery mechanisms.

Kimball stated, "Most breakthrough science occurs with radically simple and elegant solutions. What our industry has done, incorrectly in my opinion, is try to put as many ingredients as possible into a pill, thinking that more ingredients sell better to the consumer. While that might be true to a degree, I believe that it is a mass consumer 'trick' if you will, and that our consumer is very discerning, highly informed, demands efficacy, and is willing to pay for it. Our belief system is that an elegantly simple, pure, potent soft gel with the proper amount of ingredients that coincide with the research and clinical studies, will work better and faster. Results will be truly felt by the consumer."

In the creation of the formulas for Monterey Bay Nutraceuticals, Kimball directed the laboratory to "forget the cost" and create a "dream" set of products that they have always dreamed of seeing on the market, that they would be in love with, that they themselves would use and have thier families use.

"The scientists kept asking us about the costs," said Garrett Heiser, Vice President of Operations. "We had to remind them that cost was not a conversation we were going to have. We guided them to the human performance results we wanted to achieve and told them to choose the best ingredients, from the best sources, and make sure that the potency in our soft gels matched the clinical research studies, so that our consumers would see and feel results. This is not normal for the industry. Normally, a manufacturer starts with the retail price and works backwards to the cost of the ingredients. We turned the normal way of formulating upside down - making it consumer-driven and efficacy-driven - not marketing or cost driven. This may sound idealistic, but it is why we can be passionate about what we do, what we create here. This isn't about becoming the number one selling brand in the world. It's about becoming the most effective brand in the world for our specific consumer."

About Monterey Bay Nutraceuticals
Monterey Bay Nutraceuticals is a Vestiage brand. Vestiage is a publicly traded anti-aging lifestyle company offering premium-branded, science-based cosmeceuticals and nutraceuticals. Vestiage is focused on the use of human stem cell, marine/ocean, and cutting edge botanically based science and ingredients to produce highly potent, elegantly formulated, effective products with clinically proven ingredients. Using high potency and novel ingredient combinations, Vestiage creates and distributes cosmeceuticals such as Reluma (http://www.RelumaSkinCare.com) and multifunctional nutraceuticals through Monterey Bay Nutraceuticals (http://www.MontereyBayNutra.com). Vestiage brands address the top “in demand” anti-aging consumer concerns. Vestiage research is focused on longevity and human performance science that covers both the cognitive and physical realms. As clinical results validate discoveries, Vestiage intends to apply new potential ingredients or ingredient formulations and combinations to its anti-aging products across its brands. To learn more, visit the Company website, http://www.VestiageInc.com.

Read the full story at http://www.prweb.com/releases/2013/4/prweb10670025.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Liproxenol Nutraceuticals found that Liproxenol Has Been Named The Top Finisher For “Best Diet Pills Of 2012”
2. Indian Nutraceuticals Market Forecast to 2017
3. Liproxenol Nutraceuticals Adds to Collection of Weight Loss Industry Awards
4. Prescopodene Nutraceuticals named to “Best Diet Pills of 2012” list
5. Fertility Nutraceuticals, LLC Announces Partnership with Austin Marketing Agency Space Chimp Media
6. Web-Op Announces the Launch of Supplement Site EZsupplements.com
7. Grapplers Inc. Announces an Industrial Grade Grappler And Extended Reach Tool For The Most Extreme Conditions Is Now Available
8. Kentuckiana Oral and Maxillofacial Surgery Associates, PSC Announces the Hire of Will Allen, DMD
9. Contract Research Organization WCCT Global Announces Overwhelming Success of Pediatric Clinical Study Recruitment
10. New Magnetic Bracelet with Gemstones Announces Superior Magnetics
11. CBT News Announces Airing of 100th Show set for April 29th
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/28/2017)... ... June 28, 2017 , ... ... services, is proud to announce the guest speaker lineup* for its second annual ... Alliance of Healthcare Purchaser Coalitions; Dr. Keith Fernandez of Privia Health; and Lisa ...
(Date:6/28/2017)... PA (PRWEB) , ... June 28, 2017 , ... ... host a one-day corporate governance program for mid-market executives as a kick-off to ... be held Sunday, Sept. 24, 2017 on the University of Pennsylvania campus, followed ...
(Date:6/28/2017)... , ... June 28, 2017 , ... ... management and financial planning assistance to clients in southern Montana, is announcing a ... by Zoo Montana. , The outreach programs offered by Zoo Montana provide students ...
(Date:6/27/2017)... ... June 27, 2017 , ... Excel Medical, the leader ... the position of Executive Vice President, Sales and Marketing. Finnegan is a widely ... medical device sales leadership. He has received industry recognition for innovations and new ...
(Date:6/27/2017)... ... 27, 2017 , ... Salucro, the cloud-based payment platform that ... hospitals and provider groups, has announced that it will now offer Parasail’s payment ... a San Francisco health-finance startup that has launched a series of tech-based products ...
Breaking Medicine News(10 mins):
(Date:6/8/2017)... MAITLAND, Fla. , June 8, 2017  Less ... ransomware attack that hit more than 200,000 companies, including hospital ... is being heralded as one of the largest online ... technology in the healthcare market, it is imperative that ... can protect their data from this — and many ...
(Date:6/7/2017)... 2017  Novavax, Inc., (Nasdaq: NVAX ) today ... trials of its RSV F protein recombinant nanoparticle vaccine candidate ... been published in the journal Vaccine ... prior scientific conferences). The Company previously announced top line ... developing the RSV F Vaccine with the goal of protecting ...
(Date:6/3/2017)... INDIANAPOLIS , June 3, 2017  Eli ... today announced that results from the Phase 3 ... kinase (CDK)4 & 6 inhibitor, in combination with ... treatment with fulvestrant alone in women with hormone-receptor-positive ... advanced breast cancer who have relapsed or progressed ...
Breaking Medicine Technology: